|
1
|
Weinberg RA: The molecular basis of
oncogenes and tumor suppressor genes. Ann NY Acad Sci. 758:331–338.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuspa SH, Długosz AA, Cheng CK, Denning
MF, Tennenbaum T, Glick AB and Weinberg WC: Role of oncogenes and
tumor suppressor genes in multistage carcinogenesis. J Invest
Dermatol. 103:S90–S95. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lowe SW and Lin AW: Apoptosis in cancer.
Carcinogenesis. 21:485–495. 2000. View Article : Google Scholar
|
|
4
|
Brown JM and Attardi LD: The role of
apoptosis in cancer development and treatment response. Nat Rev
Cancer. 5:231–237. 2005.PubMed/NCBI
|
|
5
|
Brown JM and Wilson G: Apoptosis genes and
resistance to cancer therapy: what does the experimental and
clinical data tell us? Cancer Biol Ther. 2:477–490. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsatsanis C and Spandidos DA: Oncogenic
kinases signaling in human neoplasms. Ann NY Acad Sci.
1028:168–175. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Degterev A, Boyce M and Yuan J: A decade
of caspases. Oncogene. 22:8543–8567. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peter ME and Krammer PH: The
CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10:26–35. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Green DR and Kroemer G: The
pathophysiology of mitochondrial cell death. Science. 305:626–629.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fassetta M, D’Alessandro L, Coltella N, Di
Renzo MF and Rasola A: Hepatocyte growth factor installs a survival
platform for colorectal cancer cell invasive growth and overcomes
p38 MAPK-mediated apoptosis. Cell Signal. 18:1967–1976. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Altieri DC: Survivin and IAP proteins in
cell-death mechanisms. Biochem J. 430:199–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tokunaga E, Oki E, Egashira A, Sadanaga N,
Morita M, Kakeji Y and Maehara Y: Deregulation of the AKT pathway
in human cancer. Curr Cancer Drug Targets. 8:27–36. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mathew R: Role of autophagy in cancer. Nat
Rev Cancer. 7:961–967. 2007. View
Article : Google Scholar
|
|
14
|
Kimmelman AC: The dynamic nature of
autophagy in cancer. Genes Dev. 25:1999–2010. 2011. View Article : Google Scholar
|
|
15
|
Krick R, Muehe Y, Prick T, Bremer S,
Schlotterhose P, Eskelinen EL, Millen J, Goldfarb DS and Thumm M:
Microautophagy of the nucleus requires the core macroautophagy
genes. Mol Biol Cell. 19:4492–4505. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Farré JC and Subramani S: Peroxisome
turnover by micropexophagy: an autophagy-related process. Cell
Biol. 14:515–523. 2004.PubMed/NCBI
|
|
17
|
Periyasamy-Thandavan S, Jiang M,
Schoenlein P and Dong Z: Autophagy: molecular machinery,
regulation, and implications for renal pathophysiology. Am J
Physiol Renal Physiol. 297:F244–F256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mizushima N: The role of the Atg1/ULK1
complex in autophagy regulation. Curr Op Cell Biol. 22:132–139.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of AKT/PKB by the
rictormTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hardie D: AMP-activated/SNF1 protein
kinases: conserved guardians of cellular energy. Nat Rev Mol Cell
Biol. 8:774–781. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eisenberg-Lerner A and Kimchi A: The
paradox of autophagy and its implication in cancer etiology and
therapy. Apoptosis. 14:376–391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Djavaheri-Mergny M, Maiuri MC and Kroemer
G: Cross talk between apoptosis and autophagy by caspase-mediated
cleavage of Beclin 1. Oncogene. 29:1717–1719. 2010. View Article : Google Scholar
|
|
23
|
Wong CH, Iskandar KB, Yadav SK, Hirpara
JL, Loh T and Pervaiz S: Simultaneous induction of non-canonical
autophagy and apoptosis in cancer cells by ROS-dependent ERK and
JNK activation. PLoS One. 5:e99962010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pertwee RG: Cannabinoid receptor ligands:
clinical and neuropharmacological considerations, relevant to
future drug discovery and development. Expt Op Invest Drugs.
9:1553–1571. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guzmàn M: Cannabinoids: potential
anticancer agents. Nat Rev Cancer. 3:745–755. 2003.
|
|
26
|
Freimuth N, Ramer R and Hinz B:
Antitumorigenic effects of cannabinoids beyond apoptosis. J
Pharmacol Exp Therapeutics. 332:336–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Munson AE, Harris LS, Friedman MA, Dewey
WL and Carchman RA: Antineoplastic activity of cannabinoids. J Natl
Cancer Inst. 55:597–602. 1975.PubMed/NCBI
|
|
28
|
Demuth DG and Molleman A: Cannabinoid
signalling. Life Sci. 78:549–563. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Herrera B, Carracedo A, Diez-Zaera M,
Gómez del Pulgar T, Guzmán M and Velasco G: The CB2 cannabinoid
receptor signals apoptosis via ceramide-dependent activation of the
mitochondrial intrinsic pathway. Exp Cell Res. 312:2121–2131. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bifulco M, Malfitano AM, Pisanti S and
Laezza C: Endocannabinoids in endocrine and related tumours. Endocr
Relat Cancer. 15:391–408. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maccarrone M, Lorenzon T, Bari M, Melino G
and Finazzi-Agro A: Anandamide induces apoptosis in human cells via
vanilloid receptors. Evidence for a protective role of cannabinoid
receptors. J Biol Chem. 275:31938–31945. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Q, Liu HY, Zhang YW, Wu WJ and Tang
WX: Anandamide induces cell death through lipid rafts in hepatic
stellate cells. J Gastroenterol Hepatol. 25:991–1001. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Giuliano M, Pellerito O, Portanova P,
Calvaruso G, Santulli A, De Blasio A, Vento R and Tesoriere G:
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN:
involvement of the transcription factor PPARgamma. Biochimie.
91:457–465. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Scuderi MR, Cantarella G, Scollo M,
Lempereur L, Palumbo M, Saccani-Jotti G and Bernardini R: The
antimitogenic effect of the cannabinoid receptor agonist WIN55212-2
on human melanoma cells is mediated by the membrane lipid raft.
Cancer Lett. 310:240–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oddi S, Dainese E, Sandiford S, Fezza F,
Lanuti M, Chiurchiù V, Totaro A, Catanzaro G, Barcaroli D, De
Laurenzi V, et al: Palmitoylation of cysteine 415 of helix 8:
effect on membrane localisation and signalling of the CB(1)
cannabinoid receptor. Br J Pharmacol. 165:2635–2651. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu G, Ren G and Shi Y: The putative
cannabinoid receptor GPR55 promotes cancer cell proliferation.
Oncogene. 30:139–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gustafsson K, Christensson B, Sander B and
Flygare J: Cannabinoid receptor-mediated apoptosis induced by
R(+)-methanandamide and Win55,212-2 is associated with ceramide
accumulation and p38 activation in mantle cell lymphoma. Mol
Pharmacol. 70:1612–1620. 2006.
|
|
38
|
Blazquez C, Carracedo A, Salazar M,
Lorente M, Egia A, Gonzalez-Feria L, Haro A, Velasco G and Guzman
M: Down-regulation of tissue inhibitor of metalloproteinases-1 in
gliomas: a new marker of cannabinoid antitumoral activity?
Neuropharmacology. 54:235–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cianchi F, Papucci L, Schiavone N, Lulli
M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E,
Romagnani P, et al: Cannabinoid receptor activation induces
apoptosis through tumor necrosis factor alpha-mediated ceramide de
novo synthesis in colon cancer cells. Clin Cancer Res.
14:7691–7700. 2008. View Article : Google Scholar
|
|
40
|
Carracedo A, Gironella M, Lorente M,
Garcia S, Guzman M, Velasco G and Iovanna JL: Cannabinoids induce
apoptosis of pancreatic tumor cells via endoplasmic reticulum
stress-related genes. Cancer Res. 66:6748–6755. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Olea-Herrero N, Vara D, Malagarie-Cazenave
S and Díaz-Laviada I: The cannabinoid R+ methanandamide induces
IL-6 secretion by prostate cancer PC3 cells. J Immunotoxicol.
6:249–256. 2009.
|
|
42
|
Giuliano M, Calvaruso G, Pellerito O,
Portanova P, Carlisi D, Vento R and Tesoriere G: Anandamide-induced
apoptosis in Chang liver cells involves ceramide and JNK/AP-1
pathway. Int J Mol Med. 17:811–819. 2006.PubMed/NCBI
|
|
43
|
Massi P, Vaccani A, Bianchessi S, Costa B,
Macchi P and Parolaro D: The non-psychoactive cannabidiol triggers
caspase activation and oxidative stress in human glioma cells. Cell
Mol Life Sci. 63:2057–2066. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
McKallip RJ, Jia W, Schlomer J, Warren JW,
Nagarkatti PS and Nagarkatti M: Cannabidiol-induced apoptosis in
human leukemia cells: a novel role of cannabidiol in the regulation
of p22phox and Nox4 expression. Mol Pharmacol. 70:897–908. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Malhotra JD and Kaufman RJ: Endoplasmic
reticulum stress and oxidative stress: a vicious cycle or a
double-edged sword? Antioxid Redox Signal. 9:2277–2293. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Salazar M, Carracedo A, Salanueva IJ,
Hernández-Tiedra S, Egia A, Lorente M, Vázquez P, Torres S, Iovanna
JL, Guzmán M, et al: TRB3 links ER stress to autophagy in
cannabinoid anti-tumoral action. Autophagy. 5:1048–1049. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pellerito O, Calvaruso G, Portanova P, De
Blasio A, Santulli A, Vento R, Tesoriere G and Giuliano M: The
synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular
carcinoma cells to tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer
binding protein homologous protein (CHOP)/death receptor 5 (DR5)
axis. Mol Pharmacol. 77:854–863. 2010.
|
|
48
|
Galve-Roperh I, Sanchez C, Cortes ML, del
Pulgar TG, Izquierdo M and Guzman M: Anti-tumoral action of
cannabinoids: involvement of sustained ceramide accumulation and
extracellular signal-regulated kinase activation. Nat Med.
6:313–319. 2000. View
Article : Google Scholar
|
|
49
|
Luca T, Di Benedetto G, Scuderi MR,
Palumbo M, Clementi S, Bernardini R and Cantarella G: The CB1/CB2
receptor agonist WIN-55,212-2 reduces viability of human Kaposi’s
sarcoma cells in vitro. Eur J Pharmacol. 616:16–21. 2009.PubMed/NCBI
|
|
50
|
Park JM, Xian XS, Choi MG, Park H, Cho YK,
Lee IS, Kim SW and Chung IS: Antiproliferative mechanism of a
cannabinoid agonist by cell cycle arrest in human gastric cancer
cells. J Cell Biochem. 112:1192–1205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Piñeiro R, Maffucci T and Falasca M: The
putative cannabinoid receptor GPR55 defines a novel autocrine loop
in cancer cell proliferation. Oncogene. 30:142–152. 2011.PubMed/NCBI
|
|
52
|
Hers I, Vincent EE and Tavaré JM: Akt
signalling in health and disease. Cell Signal. 23:1515–1527. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cudaback E, Marrs W, Moeller T and Stella
N: The expression level of CB1 and CB2 receptors determines their
efficacy at inducing apoptosis in astrocytomas. PLoS One.
5:e87022010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Salazar M, Carracedo A, Salanueva IJ,
Hernández-Tiedra S, Lorente M, Egia A, Vázquez P, Blázquez C,
Torres S, García S, et al: Cannabinoid action induces
autophagy-mediated cell death through stimulation of ER stress in
human glioma cells. J Clin Invest. 119:1359–1372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Torres S, Lorente M, Rodríguez-Fornés F,
Hernández-Tiedra S, Salazar M, García-Taboada E, Barcia J, Guzmán M
and Velasco G: A combined preclinical therapy of cannabinoids and
temozolomide against glioma. Mol Cancer Ther. 10:90–103. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Vara D, Salazar M, Olea-Herrero N, Guzmán
M, Velasco G and Díaz-Laviada I: Anti-tumoral action of
cannabinoids on hepatocellular carcinoma: role of AMPK-dependent
activation of autophagy. Cell Death Differ. 18:1099–1111. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shrivastava A, Kuzontkoski PM, Groopman JE
and Prasad A: Cannabidiol induces programmed cell death in breast
cancer cells by coordinating the cross-talk between apoptosis and
autophagy. Mol Cancer Ther. 10:1161–1172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wasik AM, Almestrand S, Wang X, Hultenby
K, Dackland ÅL, Andersson P, Kimby E, Christensson B and Sander B:
WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant
MCL cells. Cell Death Dis. 2:e2252011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Donadelli M, Dando I, Zaniboni T, Costanzo
C, Dalla Pozza E, Scupoli MT, Scarpa A, Zappavigna S, Marra M,
Abbruzzese A, et al: Gemcitabine/cannabinoid combination triggers
autophagy in pancreatic cancer cells through a ROS-mediated
mechanism. Cell Death Dis. 2:e1522011. View Article : Google Scholar
|
|
60
|
Gustafsson SB, Lindgren T, Jonsson M and
Jacobsson SO: Cannabinoid receptor-independent cytotoxic effects of
cannabinoids in human colorectal carcinoma cells: synergism with
5-fluorouracil. Cancer Chemother Pharmacol. 63:691–701. 2009.
View Article : Google Scholar
|
